The NK1 receptor antagonist N-acetyl-L-tryptophan reduces dyskinesia in a hemi-parkinsonian rodent model.

Thornton, Emma

The NK1 receptor antagonist N-acetyl-L-tryptophan reduces dyskinesia in a hemi-parkinsonian rodent model. [electronic resource] - Parkinsonism & related disorders May 2014 - 508-13 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1873-5126

10.1016/j.parkreldis.2014.02.008 doi


Adrenergic Agents--toxicity
Analysis of Variance
Animals
Antiparkinson Agents--adverse effects
Dose-Response Relationship, Drug
Dyskinesia, Drug-Induced--drug therapy
Functional Laterality--drug effects
Levodopa--adverse effects
Male
Medial Forebrain Bundle--injuries
Motor Activity--drug effects
Oxidopamine--toxicity
Parkinsonian Disorders--chemically induced
Proto-Oncogene Proteins c-fos--metabolism
Rats
Rats, Sprague-Dawley
Time Factors
Tryptophan--analogs & derivatives
Tyrosine 3-Monooxygenase--metabolism